Association of paraoxonase (PON1) polymorphisms and activity with colorectal cancer predisposition

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. [pubmedMismatch][
   PubMed Web of Science ®Google Scholar
• Heavey PM, McKenna D, Rowland IR. Colorectal cancer and the relationship between genes and the environment. Nutr Cancer. 2004;48(2):124–141.
   PubMed Web of Science ®Google Scholar
• Van Der Logt EM, Janssen CH, Van Hooijdonk Z, et al. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk. Anticancer Res. 2005;25(2B):1465–1470.
   PubMed Web of Science ®Google Scholar
• Lynch HT, Lanspa S, Smyrk T, et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I. Cancer Genet Cytogenet. 1991;53(2):143–160.
   PubMedGoogle Scholar
• Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993;104(5):1535–1549.
   PubMed Web of Science ®Google Scholar
• Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood). 2004;229(7):586–597.
   PubMed Web of Science ®Google Scholar
• Sanders LM, Henderson CE, Hong MY, et al. Pro-oxidant environment of the colon compared to the small intestine may contribute to greater cancer susceptibility. Cancer Lett. 2004;208(2):155–161.
   PubMed Web of Science ®Google Scholar
• Mackness B, Durrington PN, Mackness MI. Human serum paraoxonase. Gen Pharmacol. 1998;31(3):329–336.
   PubMedGoogle Scholar
• Zhang M, Xiong H, Fang L, et al. Paraoxonase 1 (PON1) Q192R gene polymorphism and cancer risk: a meta-analysis based on 30 publications. Asian Pac J Cancer Prev. 2015;16(10):4457–4463.
   PubMedGoogle Scholar
• Arenas M, Rodriguez E, Sahebkar A, et al. Paraoxonase-1 activity in patients with cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2018;127:6–14.
   PubMed Web of Science ®Google Scholar
• Humbert R, Adler DA, Disteche CM, et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet. 1993;3(1):73–76.
   PubMed Web of Science ®Google Scholar
• Adkins S, Gan KN, Mody M, et al. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet. 1993;52(3):598–608.
   PubMed Web of Science ®Google Scholar
• Garin MC, James RW, Dussoix P, et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest. 1997;99(1):62–66.
   PubMed Web of Science ®Google Scholar
• Mackness MI, Arrol S, Mackness B, et al. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation. Lancet. 1997;349(9055):851–852.
   PubMed Web of Science ®Google Scholar
• Weber WW. Influence of heredity on human sensitivity to environmental chemicals. Environ Mol Mutagen. 1995;25(Suppl 26):102–114.
   PubMedGoogle Scholar
• Kondo I, Yamamoto M. Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson’s disease. Brain Res. 1998;806(2):271–273.
   PubMed Web of Science ®Google Scholar
• Akcay MN, Polat MF, Yilmaz I, et al. Serum paraoxonase levels in pancreatic cancer. Hepatogastroenterology. 2003;50(Suppl 2):ccxxv–ccxxvii.
   PubMedGoogle Scholar
• Akcay MN, Yilmaz I, Polat MF, et al. Serum paraoxonase levels in gastric cancer. Hepatogastroenterology. 2003;50(Suppl 2):cclxxiii–cccclxxv.
   PubMedGoogle Scholar
• Marchesani M, Hakkarainen A, Tuomainen TP, et al. New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men. J Natl Cancer Inst. 2003;95(11):812–818.
   PubMed Web of Science ®Google Scholar
• Ahmed NS, Shafik NM, Elraheem OA, et al. Association of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention. Asian Pac J Cancer Prev. 2015;16(2):803–809.
   PubMedGoogle Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
   PubMed Web of Science ®Google Scholar
• Furlong CE, Richter RJ, Seidel SL, et al. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am J Hum Genet. 1988;43(3):230–238.
   PubMed Web of Science ®Google Scholar
• Fang DH, Fan CH, Ji Q, et al. Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies. Mol Biol Rep. 2012;39(6):6801–6809.
   PubMed Web of Science ®Google Scholar
• Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat Res. 1992;275(3–6):331–342.
   PubMedGoogle Scholar
• Demple B, Harrison L. Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem. 1994;63:915–948.
   PubMed Web of Science ®Google Scholar
• Athar M. Oxidative stress and experimental carcinogenesis. Indian J Exp Biol. 2002;40(6):656–667.
   PubMedGoogle Scholar
• Sander CS, Chang H, Hamm F, et al. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int J Dermatol. 2004;43(5):326–335.
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Xu Y, Isenberg JS, et al. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect. 1998;106(Suppl 1):289–295.
   PubMed Web of Science ®Google Scholar
• Blau S, Rubinstein A, Bass P, et al. Differences in the reducing power along the rat GI tract: lower antioxidant capacity of the colon. Mol Cell Biochem. 1999;194(1–2):185–191.
   PubMed Web of Science ®Google Scholar
• Stevens VL, Rodriguez C, Talbot JT, et al. Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort. Prostate. 2008;68(12):1336–1340.
   PubMed Web of Science ®Google Scholar
• Playfer JR, Eze LC, Bullen MF, et al. Genetic polymorphism and interethnic variability of plasma paroxonase activity. J Med Genet. 1976;13(5):337–342.
   PubMed Web of Science ®Google Scholar
• Shahbazi S, Zarei S, Torfeh M, et al. Q192R variant in paraoxonase 1 gene confers susceptibility to leiomyoma. J Can Res Ther. 2020;16(4):884–887.
   PubMed Web of Science ®Google Scholar
• Ellidag HY, Eren E, Aydin O, et al. The phenotype distribution of paraoxonase-1 in patients with multiple myeloma, bladder, and colorectal cancer. J Med Biochem. 2014;33(3):252–258.
   Web of Science ®Google Scholar
• Abolhassani M, Asadikaram G, Paydar P, et al. Organochlorine and organophosphorous pesticides may induce colorectal cancer; a case-control study. Ecotoxicol Environ Saf. 2019;178:168–177.
   PubMed Web of Science ®Google Scholar
• Balci H, Genc H, Papila C, et al. Serum lipid hydroperoxide levels and paraoxonase activity in patients with lung, breast, and colorectal cancer. J Clin Lab Anal. 2012;26(3):155–160.
   PubMed Web of Science ®Google Scholar
• Yu Z, Ou Q, Chen F, et al. Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival. J Transl Med. 2018;16(1):327.
   PubMedGoogle Scholar
• Afsar CU, Gunaldı M, Okuturlar Y, et al. Paraoxonase-1 and arylesterase activities in patients with colorectal cancer. Int J Clin Exp Med. 2015;8:21599–21604.
   PubMed Web of Science ®Google Scholar
• Bulbuller N, Eren E, Ellidag HY, et al. Diagnostic value of thiols, paraoxonase 1, arylesterase and oxidative balance in colorectal cancer in human. Neoplasma. 2013;60(04):419–424.
   PubMedGoogle Scholar
• Farmohammadi A, Momeni A, Bahmani B, et al. Association of PON1-L55M genetic variation and breast cancer risk: a case-control trial. Asian Pac J Cancer Prev. 2020;21(1):255–258.
   PubMedGoogle Scholar